Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

2012/01/18 by Marı́a Elena Santolaya, María Elena Santolaya, Miguel L O'Ryan +11 · 1 voice · 2 citations
Immunology and Microbiology · Medicine · #Bacterial Infections and Vaccines #Pneumonia and Respiratory Infections #Virology and Viral Diseases

paper · doi:10.1016/s0140-6736(11)61713-3

openalex publication_date 2012/01/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia
• Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

Discussions

• Exemple 4, le vaccin contre le méningocoque, essai contre placebo. #FranceSoirFaitDeLaMerde est bien fidèle à sa sinistre réputation. 5/9 doi.org/10.1016/S014... [bsky, 6 points, 1 comments]